Keyword: Reckitt Benckiser Pharmaceuticals
Reckitt Benckiser cold and flu brand Mucinex is looking to spread COVID-19 facts instead of fear.
Pharma’s yen for direct relationships with patients isn’t new. But as new tech puts those connections within reach, it also makes them more crucial.
Cold and flu brand Mucinex made history as the first OTC drug on the TikTok music video social app, with a zombie-themed challenge promotion.
After shelling out $1.4 billion to wrap up a federal marketing probe, Reckitt Benckiser is now ponying up another $700 million in a six-state deal.
1. Reckitt Benckiser—$1.4 billion
A number of high-dollar settlements could be on the way as drugmakers look to bail on federal opioid suits. But the past two years have been thick with other deals to wrap up government investigations and lawsuits, from Medicaid fraud to False Claims Act actions.
Welcome to OmegaTown, also known as Newport, Rhode Island. This summer, RB set up camp in the seaside fishing community to put omega-3s to the test.
Consumers love to hate Reckitt Benckiser's Mr. Mucus, according to a new study.
With the feds sniffing around Indivior’s marketing of Suboxone film, the drugmaker’s former parent company is clearing its name for $1.4 billion.
In 2017, Reckitt Benckiser CEO Rakesh Kapoor touched off some big changes for the company. But he won’t stick around to see them through.
